COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often ...
Week 48 results showed that the once-weekly single tablet regimen of ISL/LEN was noninferior to BIKTARVY in maintaining virologic suppression; no (0%) participants who switched to ISL/LEN had HIV-1 ...
A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data from its research pipeline for HIV treatment and prevention will be presented at the 26th ...
Life Biosciences announced on Tuesday that the first participant in its phase 1 clinical trial has received a dose of a novel therapy called ER-100. It aims to restore aging or damaged optic nerve ...
(A) Snail1 protein expression was evaluated in vector-control and SNAI1-overexpressed HK-2 cells by immunoblotting. (B) The Snail1 band intensity was quantified and normalized by that of GAPDH ...
Single-cell transcriptomics has revolutionized our understanding of cellular diversity by enabling gene expression analysis at the individual cell level. This brief webinar will provide an overview of ...
Sporadic human infections with avian influenza A viruses have caused a wide spectrum of illness. As these novel influenza A viruses pose pandemic potential, timely detection and characterization of ...
Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study This study included 30 ...
The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically suppressed adults, Merck announced on Tuesday. Approval stipulates use of the ...
Antiretroviral medications are the main HIV treatment today. They suppress the virus and can reduce transmission risk when HIV is undetectable. Most people start antiretroviral therapy, which combines ...
Children with HIV on dolutegravir (Tivicay)-based antiretroviral therapy (ART) can safely receive the standard prophylactic tuberculosis (TB) treatment without needing to up their dolutegravir dose, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results